Delivery Order SPE2DB20D3505-SPE2DB25FU1A0

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.54, is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of December 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,705.39, is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a completion date of July 11, 2024 and is a firm fixed-price delivery order. The contract was not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,638.00 and covers the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 18, 2025. AmerisourceBergen has a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,003.09, is for the delivery of 4566999536 WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,066.76 and a period of performance through January 14, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The contract has a firm fixed price of $3,166.56 and a completion date of November 1, 2024. AmerisourceBergen, as a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,985.18 firm fixed price contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, which is a specialty medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,979.12, is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 18, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, in the amount of $2,866.50. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract is a firm fixed-price delivery order with a period of performance through January 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,562.38 contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a firm fixed price pricing type and a completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FU1A0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,769.01, is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is not designated as a set-aside.

Generated 6/2/25, 9:56 AM